Revamped Amneal Would Consider A Transformational Deal

Amneal’s new management team is open to negotiating a major transaction, even as it looks to restore organic growth through a greater focus on differentiated generic and hybrid products.

Butterfly
Amneal's new management team would consider a transformation deal, but first it wants to transform the firm's operating base • Source: Shutterstock

Amneal Pharmaceuticals' newly installed management team under co-CEOs Chirag and Chintu Patel says it is open to evaluating potential merger and acquisition opportunities, “including transformational transactions”. However, the team’s immediate focus is on improving operational efficiencies and rationalizing costs.

Outlining plans to alleviate margin pressure , in part through better supply-chain management and facility utilization, Chirag –­ who will...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business